Health4Kids Intervention Trial for Hispanic Families
Launched by THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO · Jan 21, 2015
Trial Information
Current as of May 24, 2025
Completed
Keywords
ClinConnect Summary
Given the continuing rise of the U.S. Hispanic population, reversing the Hispanic childhood obesity epidemic is critical to the nation's future health. Mexican American children and those from socioeconomically disadvantaged families often are far more overweight and obese than their peers, heightening their risk for obesity-related health complications. Our proposed randomized controlled trial, the Health4Kids (H4K) Trial for Hispanic Families, aims to improve Hispanic children's body composition by testing a comprehensive, culturally and linguistically relevant, family-oriented interventi...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * A child is eligible for the POM trial for meeting the following criteria:
- • identified by parent or legal guardian as Hispanic
- • age 6-11
- • overweight or obese (BMI between the 85th and 99.9thth (\<99th) percentile for age and gender
- • one parent/guardian that the child resides with full-time must agree to participate in intervention and evaluation activities.
- Exclusion Criteria:
- * A child will be excluded if he/she has:
- • a mental, emotional, or physical handicap identified by parents or health care provider that may interfere with study participation
- • a diagnosis of cardiovascular, pulmonary, or digestive disease
- • parent without a cell phone
- • parent unable or not willing to receive text messages
- • child or parent planning to move from the local area within the time span of the study.
About The University Of Texas Health Science Center At San Antonio
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) is a leading academic medical institution dedicated to advancing health through education, research, and patient care. As a prominent sponsor of clinical trials, UT Health San Antonio focuses on innovative medical research aimed at improving health outcomes across diverse populations. With a commitment to excellence, the institution fosters collaboration among its multidisciplinary teams to explore cutting-edge therapies and interventions. Through rigorous scientific inquiry and ethical practices, UT Health San Antonio strives to make meaningful contributions to the field of medicine and enhance the quality of life for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Antonio, Texas, United States
Patients applied
Trial Officials
Deborah M Parra-Medina, PhD
Principal Investigator
UT Health San Antonio
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials